Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region.
about
A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131Epidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysisThe sudden dominance of blaCTX-M harbouring plasmids in Shigella spp. Circulating in Southern VietnamEpidemiology of extended-spectrum β-lactamase producing Escherichia coli in the stools of returning Japanese travelers, and the risk factors for colonizationThe role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.Comparative Genome Analysis of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Sequence Type 131 Strains from Nepal and JapanEscherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain.Multi-locus variable number of tandem repeat analysis for rapid and accurate typing of virulent multidrug resistant Escherichia coli clonesEscherichia coli ST131, an intriguing clonal groupForeign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers.Comparative analysis of ESBL-positive Escherichia coli isolates from animals and humans from the UK, The Netherlands and Germany.Current epidemiology and growing resistance of gram-negative pathogens.Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections.Predictors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli infection in a Midwestern communityCountry-to-country transfer of patients and the risk of multi-resistant bacterial infection.The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae.Escherichia coli sequence type 131: epidemiology and challenges in treatment.Recent changes in the epidemiology and management of extended-spectrum β-lactamase-producing Enterobacteriaceae.Whole genome sequencing of ESBL-producing Escherichia coli isolated from patients, farm waste and canals in Thailand.The evolutionary path to extraintestinal pathogenic, drug-resistant Escherichia coli is marked by drastic reduction in detectable recombination within the core genome.Characterization of ESBL-producing Escherichia coli and Klebsiella pneumoniae from bloodstream infections in three hospitals in Bucharest, Romania: a preliminary study.Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in AustraliaEscherichia coli ST131: variations on a theme of clonal expansion.Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010.Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards.Variation in the genetic environments of bla(CTX-M-15) in Escherichia coli from the faeces of travellers returning to the United Kingdom.Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen.Characterization of Extended-Spectrum β-Lactamase-Producing Escherichia coli Strains Isolated from Retail Foods in Shaanxi Province, China.Characterization of four Escherichia coli clonal groups.High prevalence of faecal carriage of ESBL-producing Enterobacteriaceae in Norwegian patients with gastroenteritis.Prevalence of rectal colonization with multidrug-resistant Enterobacteriaceae among international patients hospitalized at Mayo Clinic, Rochester, Minnesota.Travel-associated extended-spectrum β-lactamase-producing Escherichia coli bloodstream infection following transrectal ultrasound-guided prostate biopsy.Comparative epidemiology of CTX-M-14 and CTX-M-15 producing Escherichia coli: association with distinct demographic groups in the community in New Zealand.
P2860
Q27011287-CF8FDDA0-9ED8-4CC6-BCB8-427817BE99FAQ28073332-5B68A17B-561E-4704-84AE-EF53C0D33C2CQ28474307-55F20B9B-9040-47B1-BF9F-2BE288648CFCQ28538928-36BAE963-3563-4FF3-B1C4-E73788A68CFAQ30300020-63AA5936-090E-4D05-B785-F7A16CFD380BQ30395087-FB910F3E-9134-4CAA-B79A-3421AE7C9DBFQ30396308-300C204E-2B4B-4613-B57D-AEFC3C8E5847Q31079625-B7F9809F-3569-4EE0-91CC-24B384A9002AQ34057648-26DF828F-4BDE-4D84-86CA-A75938CEF126Q34108669-2A80E322-E9DA-4AC6-89DC-15F794D13C20Q35005608-B21563A6-B357-4B21-876D-299F4523C89CQ36025192-4C832F96-A095-4A8C-89B3-D86E9944A7E4Q37247785-8F93D2B9-1D3B-4973-83AB-6F3CE81F90CBQ37562416-32371511-EEF5-4563-9880-7D8EFDFF5192Q37886438-B2C91FB6-1675-4458-B392-C4A556FB465FQ38017141-3F2C28D7-EE2C-413F-87C7-76558E992520Q38201515-EE033183-4539-4C40-99EC-D673C08E5001Q40014484-AE09003A-C735-4364-8C6D-D83C71E4510DQ40064103-61BD06A0-F947-4256-98EA-1E28D35BCAEEQ40299603-2D5FA380-6E23-4A6E-AAD3-4C0E949D4D55Q41679953-ACED278F-F876-42E0-855E-BCB2AF61DBA9Q41878231-E3E064D7-158A-4D41-A3BF-311443318BF4Q42559358-E591F80D-A374-42A9-A50E-8B00E0CA37D4Q42872176-BCC664D2-4732-460A-AF52-41CF4D2BEA81Q46247265-1510AEEA-8C29-4741-BD26-9D6871B0CC83Q47591521-65DAED6F-1FCC-4644-9E82-F715D325E617Q53133655-624C2C75-4F62-4B9B-87D2-758D316EFFA6Q53242839-134AA290-99DE-4298-86FA-5338CEDEA9C0Q53729611-768F7490-A1A1-4C55-AE3B-008CF24CD164Q54291732-4EDA0070-1F04-4DF8-B331-D8110FEDD4C7Q54296652-DF1D997F-C366-45FF-9AC3-2A3325BD8EEAQ54340523-1D4FDE1C-B550-43B8-B349-4F39CF31615CQ54343678-2BAAF894-581D-4B34-84B9-59150D1370AF
P2860
Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular characteristics of t ...... rom the Calgary Health Region.
@en
Molecular characteristics of t ...... rom the Calgary Health Region.
@nl
type
label
Molecular characteristics of t ...... rom the Calgary Health Region.
@en
Molecular characteristics of t ...... rom the Calgary Health Region.
@nl
prefLabel
Molecular characteristics of t ...... rom the Calgary Health Region.
@en
Molecular characteristics of t ...... rom the Calgary Health Region.
@nl
P2093
P2860
P356
P1476
Molecular characteristics of t ...... rom the Calgary Health Region.
@en
P2093
Daniel B Gregson
Deirdre L Church
Johann D D Pitout
Lorraine Campbell
P2860
P304
P356
10.1128/AAC.00061-09
P407
P577
2009-04-13T00:00:00Z